Mail

Australia markets closed

ALL ORDS
7,285.10
-12.60(-0.17%)
ASX 200
7,073.20
-14.10(-0.20%)
AUD/USD
0.6677
+0.0067(+1.02%)
OIL
74.38
-1.58(-2.08%)
GOLD
2,091.70
+34.50(+1.68%)
Bitcoin AUD
59,237.67
+1,146.41(+1.97%)

FEELING THE PINCH?

Beat the cost-of-living squeeze with our pro tips and helpful hacks - sign up now

Eagle Pharmaceuticals, Inc. (EGRX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD

Add to watchlist

5.95

+0.10

(+1.71%)

At close: 04:00PM EST

6.20

+0.25

(+4.20%)

After hours:

07:59PM EST

Currency in USD

Valuation measures⁴

Market cap (intra-day)	77.01M
Enterprise value	133.27M
Trailing P/E	6.98
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	0.30
Price/book (mrq)	0.31
Enterprise value/revenue	0.52
Enterprise value/EBITDA	2.38

Trading information

Stock price history

Beta (5Y monthly)	0.83
52-week change ³	-82.48%
S&P500 52-week change ³	14.90%
52-week high ³	35.82
52-week low ³	5.53
50-day moving average ³	12.29
200-day moving average ³	19.85

Share statistics

Avg vol (3-month) ³	138.63k
Avg vol (10-day) ³	311.84k
Shares outstanding ⁵	12.99M
Implied shares outstanding ⁶	12.99M
Float ⁸	11.48M
% held by insiders ¹	13.24%
% held by institutions ¹	90.41%
Shares short (14 Nov 2023) ⁴	594.6k
Short ratio (14 Nov 2023) ⁴	5.47
Short % of float (14 Nov 2023) ⁴	7.09%
Short % of shares outstanding (14 Nov 2023) ⁴	4.58%
Shares short (prior month 12 Oct 2023) ⁴	602.89k

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	30 Dec 2022
Most-recent quarter (mrq)	29 June 2023

Profitability

Profit margin	4.64%
Operating margin (ttm)	15.94%

Management effectiveness

Return on assets (ttm)	6.63%
Return on equity (ttm)	4.88%

Income statement

Revenue (ttm)	257.55M
Revenue per share (ttm)	19.68
Quarterly revenue growth (yoy)	-12.80%
Gross profit (ttm)	221.67M
EBITDA	62.33M
Net income avi to common (ttm)	11.95M
Diluted EPS (ttm)	0.85
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	15.35M
Total cash per share (mrq)	1.18
Total debt (mrq)	72.45M
Total debt/equity (mrq)	28.75%
Current ratio (mrq)	2.16
Book value per share (mrq)	19.25

Cash flow statement

Operating cash flow (ttm)	-9.32M
Levered free cash flow (ttm)	38.31M